Cargando…
Impact of BSG/CD147 gene expression on diagnostic, prognostic and therapeutic strategies towards malignant cancers and possible susceptibility to SARS-CoV-2
BACKGROUND: BSG (CD147) is a member of the immunoglobulin superfamily that shows roles for potential prognostics and therapeutics for metastatic cancers and SARS-CoV-2 invasion for COVID-19. The susceptibility of malignant cancers to SARS-CoV-2 as well as the correlations between disease outcome and...
Autores principales: | Fu, Jiewen, Song, Binghui, Du, Jiaman, Liu, Shuguang, He, Jiayue, Xiao, Ting, Zhou, Baixu, Li, Dabing, Liu, Xiaoyan, He, Tao, Cheng, Jingliang, Fu, Junjiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793814/ https://www.ncbi.nlm.nih.gov/pubmed/36574092 http://dx.doi.org/10.1007/s11033-022-08231-1 |
Ejemplares similares
-
Impact of TMPRSS2 Expression, Mutation Prognostics, and Small Molecule (CD, AD, TQ, and TQFL12) Inhibition on Pan-Cancer Tumors and Susceptibility to SARS-CoV-2
por: Fu, Jiewen, et al.
Publicado: (2022) -
COVID-19 disease and malignant cancers: The impact for the furin gene expression in susceptibility to SARS-CoV-2
por: Li, Dabing, et al.
Publicado: (2021) -
COVID-19 receptor and malignant cancers: Association of CTSL expression with susceptibility to SARS-CoV-2
por: Zhang, Lianmei, et al.
Publicado: (2022) -
The regulation of ISG20 expression on SARS-CoV-2 infection in cancer patients and healthy individuals
por: Cheng, Jingliang, et al.
Publicado: (2022) -
Prostate adenocarcinoma and COVID‐19: The possible impacts of TMPRSS2 expressions in susceptibility to SARS‐CoV‐2
por: Cheng, Jingliang, et al.
Publicado: (2021)